drugset / Trial / NCT02652351
Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis
Phase 1
Unknown
20 enrolled
Shenzhen Hornetcorn Bio-technology Company, LTD
The Second Hospital University of South China · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cell(hUC-MSC) for Hepatic Cirrhosis.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-05
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 2e+07 cells | Intravenous |